Results for:(157 found)
Dec 27, 2012 2:15PM on Top StocksBy Wall St. Cheat Sheet

The worst performers one year turn into the better performers the next -- at least in theory.

Dec 27, 2012 11:51AM on Top StocksBy Minyanville.com

Biogen Idec, Pfizer, Bristol-Myers and Celgene are among companies awaiting US approval of key treatments.

Dec 27, 2012 9:03AM on Top StocksBy Stock Traders Daily

The market is growing and the opportunities are there, but so are the risks.

Dec 17, 2012 11:46AM on Top StocksBy Benzinga

Look to this pair of underperformers to make a potential positive shift in the new year.

Dec 11, 2012 6:24PM on Top StocksBy Jim J. Jubak

There are better pipelines in the industry at a better price.

Tags: BMYPFE
Dec 3, 2012 12:25PM on Top StocksBy TheStreet Staff

But expect the Affordable Care Act and prescriber pushback to curb drug-pricing power.

Nov 19, 2012 1:11PM on Top StocksBy InvestorPlace

These stocks are ripe for a turnaround.

Nov 9, 2012 3:37PM on Top StocksBy Trefis

The approval of the rheumatoid arthritis treatment will help douse recent concerns about its pipeline.

Tags: ABTJNJPFE

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More